Projects per year
Personal profile
Education
- 2014 Ph.D., The Institute of Basic Medical Sciences, National Cheng Kung University
Experience
- 2023.02- Associate Professor, Department of Anatomy and Cell Biology, School of Medicine, College of Medicine, Taipei Medical University
- 2019.10-2023.01 Assistant Professor, Department of Anatomy and Cell Biology, School of Medicine, College of Medicine, Taipei Medical University
- 2017.08-2019.09 Postdoctoral Research Fellow, National Cheng Kung University
- 2015.08-2017.07 Postdoctoral Researcher, Academia Sinica
- 2014.08-2015.06 Postdoctoral Assistant Researcher, National Cheng Kung University
Awards
- 2017 Outstanding Poster Award of Institute of Cellular and Organismic Biology, Academia Sinica
- 2015 First Place, The 14st AAROC Graduate Student Poster Presentation Award
- 2014 Excellent Research Award, Institute of Basic Medical Sciences, National Cheng Kung University
- 2013 Research Award, Liver Disease Prevention & Treatment Research Foundation
- 2012 Second Place, The 12st AAROC Graduate Student Poster Presentation Award
Research Interests
- Cell Death Regulation
- Signal Transduction
- Antimicrobial Peptides
Fingerprint
Dive into the research topics where Bor-Chyuan Su is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Evaluation of Multifaceted Antigastric Cancer Activity of Fish Antimicrobial Peptides Using Patient-Derived Tumor Organoids: Cancer Cell Killing and Cancer Immunity
Su, B.-C. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
Repurposing Diuretics as an Anti-Osteosarcoma Drug: the Impact of Diuretics on Cell Survival, Migration and Metabolism
Su, B.-C. (PI)
8/1/21 → 7/31/22
Project: A - Government Institution › b - National Science and Technology Council
-
探討Hedgehog訊息途徑在數種抗癌藥物毒殺非小細胞型肺癌細胞之角色與測試結合式治療的功效(2/2)
Su, B.-C. (PI)
2/1/21 → 7/31/21
Project: A - Government Institution › b - National Science and Technology Council
-
The Role of Hedgehog Signaling in Anticancer Agent-Induced Cytotoxicity in Non-Small Cell Lung Cancer Cells and the Efficacy of Combination Therapy(1/2)
Su, B.-C. (PI)
2/1/20 → 1/31/21
Project: A - Government Institution › b - National Science and Technology Council
Research output
- 34 Article
-
Antihypertensive agent losartan promotes tongue squamous cell carcinoma cell proliferation via EGFR/ERK1/2/cyclin D1 signaling axis
Wu, L. Y., Su, B. C., Yu, H. H., Cheng, C. C., Tsai, C. C., Hsu, P. L. & Lee, C. W., Dec 2024, In: Journal of Oral Biosciences. 66, 4, p. 74-80 7 p.Research output: Contribution to journal › Article › peer-review
-
Combination of Vismodegib and Paclitaxel Enhances Cytotoxicity via Bak-mediated Mitochondrial Damage in EGFR-Mutant Non-Small Cell Lung Cancer Cells
Yeh, W. C., Tu, Y. C., Hsu, P. L., Lee, C. W., Yu, H. H. & Su, B. C., Dec 2024, In: Cell Biochemistry and Biophysics. 82, 4, p. 3499-3506 8 p.Research output: Contribution to journal › Article › peer-review
-
Impacts of hyperthermic chemotherapeutic agent on cytotoxicity, chemoresistance-related proteins and PD-L1 expression in human gastric cancer cells
Su, B. C., Chen, G. Y., Yang, C. M., Chuang, W. T., Lin, M. C., Hsu, P. L., Lee, C. W., Cheng, C. C., Wu, S. Y., Pan, B. S. & Yu, H. H., 2024, In: International Journal of Hyperthermia. 41, 1, 2310017.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus) -
Marine Antimicrobial Peptide Epinecidin-1 Inhibits Proliferation Induced by Lipoteichoic acid and Causes cell Death in non-small cell lung cancer Cells via Mitochondria Damage
Yu, H. H., Wu, L. Y., Hsu, P. L., Lee, C. W. & Su, B. C., Oct 2024, In: Probiotics and Antimicrobial Proteins. 16, 5, p. 1724-1733 10 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Citations (Scopus) -
Repurposing the diuretic benzamil as an anti-osteosarcoma agent that acts by suppressing integrin/FAK/STAT3 signalling and compromising mitochondrial function
Lin, M.-C., Chen, G.-Y., Yu, H.-H., Hsu, P. L., Lee, C. W., Cheng, C.-C., Wu, S.-Y., Pan, B.-S. & Su, B.-C., Apr 4 2024, In: Bone and Joint Research. 13, 4, p. 157-168 12 p.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus)